Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cleveland BioLabs Company Profile (NASDAQ:CBLI)

Consensus Ratings for Cleveland BioLabs (NASDAQ:CBLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cleveland BioLabs (NASDAQ:CBLI)
Show:
DateFirmActionRatingPrice TargetActions
1/24/2014Cantor FitzgeraldDowngradeBuy -> Hold$4.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014OppenheimerDowngradeOutperform -> Market Perform$0.75 -> $1.13View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2013 forward)